Alivus Life Sciences
Ahmedabad, India
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (2)
○ Clinical Trials
○ SEC Filings
✓ Press (1)
○ EMA GMP
○ MHRA GMP
✓ HC GMP (3)
Quick Facts: Alivus Life Sciences
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Ahmedabad, India
- Website
- https://www.alivus.com/
- Modalities
- Small Molecule API, Intermediates, Custom Synthesis
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Alivus Life Sciences
Alivus Life Sciences makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API, Intermediates, Custom Synthesis. 3 manufacturing sites registered with the U.S. FDA and Health Canada. Website: https://www.alivus.com/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Alivus Life Sciences FDA Inspection History
2025-05
2025-01
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-05-30 |
Alivus Life Sciences Limited
Bharuch
Company-level
|
Drug Quality Assurance | No | No Action Indicated (NAI) |
| 2025-01-31 |
Alivus Life Sciences Limited
Ankleshwar
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Oct 31, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Company Signals 1 articles
Company announcements, not verified evidence. They do not change any score.
Alivus Life Sciences Acquires 9.21% Stake In Torrent Urja 19 To Boost Renewable Focus - Sahi
Alivus Life Sciences Acquires 9.21% Stake In Torrent Urja 19 To Boost Renewable Focus Sahi
Frequently Asked Questions About Alivus Life Sciences
How many FDA inspections does Alivus Life Sciences have on record?
CDMO Signal tracks 2 FDA inspections for Alivus Life Sciences, sourced from the FDA inspection database. See the full inspection history above.
Has Alivus Life Sciences received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Alivus Life Sciences.
Does Alivus Life Sciences have a CDMO Signal Score?
Not yet. Alivus Life Sciences is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Alivus Life Sciences for a manufacturing program?
Use the free AI matchmaker to compare Alivus Life Sciences against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Divi's Laboratories
Hyderabad, Telangana, India
Small Molecule API, Intermediates, Custom Synthesis, Peptides
Indoco Remedies
Mumbai, India
Small Molecule API, Intermediates, Custom Synthesis, Oral Solid Dose, Topicals
Honour Lab
Hyderabad, Telangana, India
Small Molecule API, Intermediates, Custom Synthesis
Hy-Gro Chemicals Pharmtek
Hyderabad, Telangana, India
Small Molecule API, Intermediates, Custom Synthesis
Vasudha Pharma Chem
Hyderabad, Telangana, India
Small Molecule API, Intermediates, Custom Synthesis
Compare Alivus Life Sciences with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.